Ex Parte RedaDownload PDFPatent Trial and Appeal BoardSep 7, 201713838973 (P.T.A.B. Sep. 7, 2017) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 13/838,973 03/15/2013 Kareem Reda Y14.12-0005 8207 27367 7590 09/11/2017 WESTMAN CHAMPLIN & KOEHLER, P.A. SUITE 1400 900 SECOND AVENUE SOUTH MINNEAPOLIS, MN 55402 EXAMINER YIP, WINNIE S ART UNIT PAPER NUMBER 3636 NOTIFICATION DATE DELIVERY MODE 09/11/2017 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): docketing @ wck.com tsorbel@wck.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte KAREEM RED A Appeal 2017-003782 Application 13/838,973 Technology Center 3600 Before JOSEPH L. DIXON, ERIC S. FRAHM, and JOYCE CRAIG, Administrative Patent Judges. FRAHM, Administrative Patent Judge. DECISION ON APPEAL Appeal 2017-003782 Application 13/838,973 STATEMENT OF THE CASE This is a decision on appeal under 35 U.S.C. § 134(a) from the Final Rejection of claims 1—5. We have jurisdiction under 35 U.S.C. § 6(b). We reverse. The Examiner has rejected (i) claims 1—3 under 35 U.S.C. § 112(b) as being indefinite; (ii) claims 1 and 3 under 35 U.S.C. § 102(b) as being anticipated by Stuby (US 2013/0256253 Al; published Oct. 3, 2013) (Non- Final Act. 3^4 (mailed June 23, 2015); Ans. 3); (iii) claims 1—3 under 35 U.S.C. § 102(b) as being anticipated by both Varon (US 4,316,547; issued Feb. 23, 1982) and Kanai (US 5,368,364; issued Nov. 29, 1994); and (iv) claims 1—5 under 35 U.S.C. § 103(a) as being unpatentable over Hsia (US 5,765,922; issued June 16, 1998) in view of Barron (US 4,557,446; issued Dec. 10, 1985) (Non-Final Act. 2—6; Ans. 2—6; Suppl. Ans. 3—7). The Examiner has withdrawn the rejection of claims 1—3 under 35 U.S.C. § 112(b) as being indefinite (Ans. 6; Suppl. Ans. 7). We agree with the Examiner (Ans. 6; Suppl. Ans. 7) that claim 1 recites a walker frame and a tray in the preamble (as is also recited in the body of claim 1), but we do not agree with the Examiner that the recitation in claim 1 recites merely an intended use. We disagree with the Examiner’s basic premise of interpreting claim 1 as a sub-combination which only recites a spacer, and not giving the claim terms “a walker frame” and “a removable tray” any patentable weight based on not being positively recited in the body of the claim (Non-Final Act. 3—5; Ans. 3—5; Suppl. Ans. 4—6). “During examination, ‘claims . . . are to be given their broadest reasonable interpretation consistent with the specification, and . . . claim language should be read in light of the specification as it would be 2 Appeal 2017-003782 Application 13/838,973 interpreted by one of ordinary skill in the art.’” In re Am. Acad, of Sci. Tech. Ctr., 367 F.3d 1359, 1364 (Fed. Cir. 2004); In re Morris, 127 F.3d 1048, 1053—54 (Fed. Cir. 1997). Further, a claim term should be given its ordinary meaning in the pertinent context, unless the patentee has made clear its adoption of a different definition or otherwise disclaimed that meaning. See, e.g., Thornerv. Sony ComputerEntm’t Am. LLC, 669 F.3d 1362, 1365 (Fed. Cir. 2012). When construing asserted claims, claim terms are given “their ordinary and accustomed meaning as understood by one of ordinary skill in the art.” Dow Chem. Co. v. Sumitomo Chem. Co., 257 F.3d 1364, 1372 (Fed. Cir. 2001); Phillips v. AWHCorp., 415 F.3d 1303, 1312-13 (Fed. Cir. 2005) (en banc). And, intrinsic evidence, such as “the specification,. . . may shed contextual light” on the ordinary and customary meaning of a claim term. Aventis Pharms. Inc. v. Amino Chems. Ltd., 715 F.3d 1363, 1373 (Fed. Cir. 2013). “The construction that stays true to the claim language and most naturally aligns with the patent’s description of the invention will be, in the end, the correct construction.” Phillips, 415 F.3d at 1316. And, because a patent is a fully integrated written instrument, the claims “must be read in view of the specification, of which they are a part.” Phillips, 415 F.3d at 1315 (quoting Markman v. WestviewInstruments, Inc., 52 F.3d 967, 979 (Fed. Cir. 1995) (enbanc), aff’d, 517 U.S. 370 (1996)). “Whether to treat a preamble as a limitation is a determination resolved only on review of the entire [ ] . . . patent to gain an understanding of what the inventors actually invented and intended to encompass by the claim.” Catalina Mktg. Int’l, Inc. v. Coolsavings.com, Inc., 289 F.3d 801, 808 (Fed. Cir. 2002) (internal quotation marks, brackets, and citation omitted); see Applied Materials, Inc. v. Advanced Semiconductor 3 Appeal 2017-003782 Application 13/838,973 Materials Am., Inc., 98 F.3d 1563, 1572-73 (Fed. Cir. 1996) (stating that whether the preamble constitutes a limitation “is determined on the facts of each case in light of the overall form of the claim, and the invention as described in the specification and illuminated in the prosecution history”). “[TJhere is no simple test” for understanding the import of the preamble, but “we have set forth some general principles to guide th[e] inquiry.” Am. Med. Sys., Inc. v. Biolitec, Inc., 618 F.3d 1354, 1358 (Fed. Cir. 2010). “Generally, the preamble does not limit the claims.” Allen Eng ’g Corp. v. BartellIndus., Inc., 299 F.3d 1336, 1346 (Fed. Cir. 2002) (citation omitted). However, a preamble may be limiting if: “it recites essential structure or steps”; claims “depend[] on a particular disputed preamble phrase for antecedent basis”; the preamble “is essential to understand limitations or terms in the claim body”; the preamble “recit[es] additional structure or steps underscored as important by the specification”; or there was “clear reliance on the preamble during prosecution to distinguish the claimed invention from the prior art.” Catalina Mktg., 289 F.3d at 808 (citations omitted). On the other hand, the reverse is also true. A preamble is not a claim limitation if the claim body “defines a structurally complete invention . . . and uses the preamble only to state a purpose or intended use for the invention.” Rowe v. Dror, 112 F.3d 473, 478 (Fed. Cir. 1997). “[PJreamble language merely extolling benefits or features of the claimed invention does not limit the claim scope without clear reliance on those benefits or features as patentably significant.” Catalina Mktg., 289 F.3d at 809 (citations omitted). 4 Appeal 2017-003782 Application 13/838,973 We have reviewed Appellant’s arguments in the Appeal Briefs (Br. 9— 25), the Examiner’s rejection (Non-Final Act. 3—6; Ans. 2—6; Suppl. Ans. 3— 7), and the Examiner’s response (Ans. 7—16; Suppl. Ans. 8—17) to Appellant’s arguments. Independent claims 1 and 4 on appeal both positively recite a mechanism and methods for securing/attaching “a removable walker tray to a walker frame.” Each of independent claims 1 and 4 also require at least one spacer with a surface for frictionally engaging a walker handle and the removable walker tray. We find the body of the claim ties in with the preamble to breathe life into the limitations “removable tray” and “walker frame” (clearly and plainly, a walker frame is the frame of a walker, thus requiring the presence of a walker). In light of Appellant’s Figures 1 and 7, showing a walker and/or removable tray for a walker, as well as the Title (Method and Mechanism for Securing a Removable Tray to a Walker), it is clear that the preamble must be treated as a limitation based on our review of the entire patent application. Catalina Mktg., 289 F.3d at 808. In other words, our review of the entire application on appeal reveals that what Appellant intends the claim to encompass is a walker with a removable tray. Therefore, we are constrained by the record before us to conclude that the Examiner erred in rejecting claims 1—5 on the basis that the recited walker frame and tray are not to be given patentable weight when interpreting the claims, leaving claim 1 only to claim a spacer, and claim 4 only to claim a chair, as opposed to a walker with a removable tray. In view of the foregoing, we do not sustain the Examiner’s (i) anticipation rejections of claims 1—3, and/or (ii) obviousness rejection of claims 1—5. 5 Appeal 2017-003782 Application 13/838,973 CONCLUSION Appellant has persuaded us of error in the Examiner’s decision to reject claims 1—5. DECISION We reverse the decision of the Examiner to reject claims 1—5. REVERSED 6 Copy with citationCopy as parenthetical citation